Already a subscriber? - Login here
Not yet a subscriber? - Subscribe here

Browse by:



Displaying: 1-6 of 6 documents


1. Business and Professional Ethics Journal: Volume > 39 > Issue: 3
David Bevan, Kenneth E. Goodpaster

view |  rights & permissions | cited by

2. Business and Professional Ethics Journal: Volume > 39 > Issue: 3
Thomas Hemphill, Scott Johnson

abstract | view |  rights & permissions | cited by
Is it socially responsible to price at a premium, company branded generic pharmaceuticals in emerging economies? Building toward an answer to this question, the study first describes the role of the branded generic sector in the economic success of the global pharmaceutical industry. Second, the concept of “shared value,” i.e., the link between competitive advantage (and its theoretical antecedents found in corporate reputation and signaling theory) and corporate social responsibility (CSR), is introduced and applied to the global pharmaceutical industry’s position on marketing generic pharmaceuticals. Third, an empirical evaluation ascertains whether there is sufficient shared value for this company branded generics pricing strategy to be considered “socially responsible.” Fourth, after concluding there is sufficient shared value, a discussion section offers a public/private (corporate and industry self-regulation) framework that will help ensure that safe and effective pharmaceuticals are sold to consumers in developing economies. Lastly, a summary and conclusion section completes the article.

3. Business and Professional Ethics Journal: Volume > 39 > Issue: 3
Wenling Lu, Benjamin Yeo

abstract | view |  rights & permissions | cited by
This study examines the relationship between corporate social responsibility (CSR), a central ethical concern, and firm total risk, a central business concern, using a large US dataset spanning 1991 to 2015. It includes considerations for the recent financial crisis to establish whether firm engagement in specific CSR dimensions decrease (i.e., the risk reduction hypothesis) or increase (i.e., the resource constraint hypothesis) firm risk. The findings demonstrate the impact of CSR engagement is different, depending on the specific CSR dimension in question, and the relationship between each of the seven CSR dimensions and total risk is time varying. Our empirical evidence suggests that firms should prioritize different CSR dimensions as an integral part of their CSR strategies and strategic management and change the priority in different market conditions.

4. Business and Professional Ethics Journal: Volume > 39 > Issue: 3
Marianne Thejls Ziegler

abstract | view |  rights & permissions | cited by
This article outlines different attempts to define integrity, and argues, with reference to the theory of moral particularism, that definitions acquire universal applicability at the expense of their informative value. The article then proceeds to more delimitating definitions that emphasise the social aspect, and argues that their ideas of the concept, like courage, require certain situations in order to unfold. Since not every person is challenged to act with integrity, the delimitation requires a distinction between manifest integrity and dormant integrity, or dormant lack of integrity. Persons of influence, like politicians and managers, on the other hand, are challenged on a regular basis because their position requires communication of values in a public space, against which the public can evaluate their actions. A delimitating definition therefore ties the question of integrity to people in leading positions.

book review

5. Business and Professional Ethics Journal: Volume > 39 > Issue: 3
Ashley Whitaker

view |  rights & permissions | cited by

6. Business and Professional Ethics Journal: Volume > 39 > Issue: 3

view |  rights & permissions | cited by